| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $78K | — | -92.9% |
| R&D Expense | $19.5M | — | +32.6% |
| SG&A Expense | $7.1M | — | -14.4% |
| Operating Income | -$26.5M | — | -21.1% |
| Net Income | -$39.2M | — | -121.2% |
| EPS (Basic) | -$1.46 | — | -114.7% |
| EPS (Diluted) | -$1.46 | — | -114.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $118.6M | -5.2% | -34.2% |
| Accounts Receivable | $261K | -76.6% | -85.2% |
| Current Assets | $122.0M | -5.6% | -34.1% |
| Total Assets | $288.4M | -2.7% | -29.5% |
| Current Liabilities | $15.9M | +6.7% | +6.3% |
| Total Liabilities | $436.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$22.1M | — | +4.2% |
| Capital Expenditures | $27K | — | -97.5% |
| Investing Cash Flow | -$27K | — | +97.5% |
| Financing Cash Flow | $15.7M | — | +295.3% |
| Free Cash Flow | -$22.2M | — | +8.4% |
| +1.3% |
| Stockholders' Equity | -$148.1M | -17.3% | -579.8% |